September 14, 2020
President Trump yesterday signed an additional executive order aimed at lowering the price of prescription drugs. Three executive orders were signed in July seeking to do the same. Yesterday’s order directs the Secretary of Health and Human Services (HHS) to test a “most-favored-nation” pricing model for Part B, and some Part D, drugs. View highlights under key resources.